The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Cancer active targeting by nanoparticles: a comprehensive review of literature
Open accessAbstract
PurposeCancer is one of the leading causes of death, and thus, the scientific community has but great efforts to improve cancer management. Among the major challenges in cancer management is development of agents that can be used for early diagnosis and effective therapy. Conventional cancer management frequently lacks accurate tools for detection of early tumors and has an associated risk of serious side effects of chemotherapeutics. The need to optimize therapeutic ratio as the difference with which a treatment affects cancer cells versus healthy tissues lead to idea that it is needful to have a treatment that could act a the “magic bullet”—recognize cancer cells only. Nanoparticle platforms offer a variety of potentially efficient solutions for development of targeted agents that can be exploited for cancer diagnosis and treatment. There are two ways by which targeting of nanoparticles can be achieved, namely passive and active targeting. Passive targeting allows for the efficient localization of nanoparticles within the tumor microenvironment. Active targeting facilitates the active uptake of nanoparticles by the tumor cells themselves.MethodsRelevant English electronic databases and scientifically published original articles and reviews were systematically searched for the purpose of this review.ResultsIn this report, we present a comprehensive review of literatures focusing on the active targeting of nanoparticles to cancer cells, including antibody and antibody fragment-based targeting, antigen-based targeting, aptamer-based targeting, as well as ligand-based targeting.ConclusionTo date, the optimum targeting strategy has not yet been announced, each has its own advantages and disadvantages even though a number of them have found their way for clinical application. Perhaps, a combination of strategies can be employed to improve the precision of drug delivery, paving the way for a more effective personalized therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
Zhang, Y., Kohler, N., & Zhang, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00267-8 · Cited by 1,264
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061 · cited 1×
“In addition, TfR is also expressed on the brain capillary endothelial cells (Jefferies et al. 1984).”
BackgroundBagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
Nahta, R., Yu, D., Hung, M.-C., Hortobagyi, G. N., & Esteva, F. J. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0509 · Cited by 916
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
In Vivo Magnetic Resonance Detection of Cancer by Using Multifunctional Magnetic Nanocrystals
Huh, Y.-M., Jun, Y.-W., Song, H.-T., Kim, S., Choi, J.-S., Lee, J.-H., Yoon, S., Kim, K.-S., Shin, J.-S., Suh, J.-S., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052337c · Cited by 859
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
Fan, K., Cao, C., Pan, Y., Lu, D., Yang, D., Feng, J., Song, L., Liang, M., & Yan, X. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.90 · Cited by 753
Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach
Fang, X., & Tan, W. (2010) · Accounts of Chemical Research · doi:10.1021/ar900101s · Cited by 747
Kim, D., Jeong, Y. Y., & Jon, S. (2010) · ACS Nano · doi:10.1021/nn901877h · Cited by 726
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Elnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649
Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.
Press, M. F., Cordon‐Cardo, C., & Slamon, D. J. (1990) · PubMed · Cited by 638
Immunotherapy: past, present and future
Waldmann, T. A. (2003) · Nature Medicine · doi:10.1038/nm0303-269 · Cited by 628
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Nanoparticles—a historical perspective
KREUTER, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.021 · Cited by 540
Spector, N. L., & Blackwell, K. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1507 · Cited by 497
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.1.45 · Cited by 456
Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells
Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D., & Tan, W. (2006) · Analytical Chemistry · doi:10.1021/ac052015r · Cited by 431
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Matherly, L. H., & Goldman, I. D. (2003) · Vitamins & Hormones · doi:10.1016/s0083-6729(03)01012-4 · Cited by 386
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy
Dilnawaz, F., Singh, A., Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.057 · Cited by 385
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Yang, L., Mao, H., Wang, Y. A., Cao, Z., Peng, X., Wang, X., Duan, H., Ni, C., Yuan, Q., Adams, G., et al. (2009) · Small · doi:10.1002/smll.200800714 · Cited by 356
Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Ni, X., Castanares, M., Mukherjee, A., & Lupold, S. E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189600 · Cited by 349
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Aptamer−Nanoparticle Strip Biosensor for Sensitive Detection of Cancer Cells
Liu, G., Mao, X., Phillips, J. A., Xu, H., Tan, W., & Zeng, L. (2009) · Analytical Chemistry · doi:10.1021/ac901889s · Cited by 340
Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.048 · Cited by 337
Sahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Dendrimer‐Entrapped Gold Nanoparticles as a Platform for Cancer‐Cell Targeting and Imaging
Shi, X., Wang, S., Meshinchi, S., Van Antwerp, M. E., Bi, X., Lee, I., & Baker, J. R. (2007) · Small · doi:10.1002/smll.200700054 · Cited by 318
Wang, A. Z., Bagalkot, V., Vasilliou, C. C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M. J., Langer, R., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800091 · Cited by 312
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
Huang, Y.-F., Chang, H.-T., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac702322j · Cited by 303
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
Lee, J. H., Yigit, M. V., Mazumdar, D., & Lu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.003 · Cited by 293
Hwang, D. W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S., & Kim, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069880 · Cited by 293
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
Li, X., Ding, L., Xu, Y., Wang, Y., & Ping, Q. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.023 · Cited by 274
Biofunctionalized targeted nanoparticles for therapeutic applications
Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1063 · Cited by 270
Cetuximab: An epidermal growth factor receptor chimeric human-murine monoclonal antibody
Harding, J., & Burtness, B. (2005) · Drugs of Today · doi:10.1358/dot.2005.41.2.882662 · Cited by 261
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers
Chen, H. W., Medley, C. D., Sefah, K., Shangguan, D., Tang, Z., Meng, L., Smith, J. E., & Tan, W. (2008) · ChemMedChem · doi:10.1002/cmdc.200800030 · Cited by 250
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Choi, H., Choi, S. R., Zhou, R., Kung, H. F., & Chen, I.-W. (2004) · Academic Radiology · doi:10.1016/j.acra.2004.04.018 · Cited by 240
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 230
Yu, M. K., Kim, D., Lee, I., So, J., Jeong, Y. Y., & Jon, S. (2011) · Small · doi:10.1002/smll.201100472 · Cited by 225
Ling, Y., Wei, K., Luo, Y., Gao, X., & Zhong, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.089 · Cited by 223
Wang, H., Zheng, L., Peng, C., Shen, M., Shi, X., & Zhang, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.054 · Cited by 219
Xu, L., Pirollo, K. F., Tang, W.-H., Rait, A., & Chang, E. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016357 · Cited by 218
Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K., Sekine, T., Ishida, O., Ogiwara, N., Johkura, K., & Yonemura, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10242 · Cited by 216
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 216
Targeted Drugs and Nanomedicine: Present and Future
Debbage, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787002870 · Cited by 213
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
Gan, C. W., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.053 · Cited by 207
Pan, X. Q., Zheng, X., Shi, G., Wang, H., Ratnam, M., & Lee, R. J. (2002) · Blood · doi:10.1182/blood.v100.2.594 · Cited by 200
Manju, S., & Sreenivasan, K. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.11.024 · Cited by 197
In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer Nanoparticles
Thomas, T. P., Patri, A. K., Myc, A., Myaing, M. T., Ye, J. Y., Norris, T. B., & Baker, J. R. (2004) · Biomacromolecules · doi:10.1021/bm049704h · Cited by 193
Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X.-D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190
Kobayashi, T., Ishida, T., Okada, Y., Ise, S., Harashima, H., & Kiwada, H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.039 · Cited by 170
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1215/s1522851799000307 · Cited by 168
Glazer, E. S., Zhu, C., Massey, K. L., Thompson, C. S., Kaluarachchi, W. D., Hamir, A. N., & Curley, S. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2055 · Cited by 161
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Hathaway, H. J., Butler, K. S., Adolphi, N. L., Lovato, D. M., Belfon, R., Fegan, D. L., Monson, T., Trujillo, J. E., Tessier, T. E., Bryant, H. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr3050 · Cited by 158
Taghdisi, S. M., Lavaee, P., Ramezani, M., & Abnous, K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.005 · Cited by 157
Zhou, Y., Drummond, D. C., Zou, H., Hayes, M. E., Adams, G. P., Kirpotin, D. B., & Marks, J. D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.011 · Cited by 151
Aptamer-Functionalized Nano-Biosensors
Chiu, T., & Huang, C. (2009) · Sensors · doi:10.3390/s91210356 · Cited by 149
In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery
Xu, Z., Gu, W., Huang, J. C., Sui, H., Zhou, Z., Yang, Y., Zhou, Y., & Li, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.009 · Cited by 147
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 143
Day, E. S. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s10881 · Cited by 143
Anabousi, S., Bakowsky, U., Schneider, M., Huwer, H., Lehr, C., & Ehrhardt, C. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.07.004 · Cited by 141
Biodegradable Nanoparticles for Direct or Two-Step Tumor Immunotargeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050137k · Cited by 139
Shmeeda, H., Mak, L., Tzemach, D., Astrahan, P., Tarshish, M., & Gabizon, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0543 · Cited by 137
Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFR
Pan, X., Wu, G. J., Yang, W., Barth, R. F., Tjarks, W., & Lee, R. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060174r · Cited by 134
Smart Multifunctional Nanostructure for Targeted Cancer Chemotherapy and Magnetic Resonance Imaging
Chen, T., Shukoor, M. I., Wang, R., Zhao, Z., Yuan, Q., Bamrungsap, S., Xiong, X., & Tan, W. (2011) · ACS Nano · doi:10.1021/nn202073m · Cited by 133
Tumor-Targeted Drug Delivery with Aptamers
Zhang, Y., Hong, H., & Cai, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189547 · Cited by 131
Lu, R., Chang, Y., Chen, M., & Wu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.061 · Cited by 129
Directed evolution of gold nanoparticle delivery to cells
Li, N., Larson, T. A., Nguyen, H. H., Sokolov, K., & Ellington, A. D. (2009) · Chemical Communications · doi:10.1039/b920865h · Cited by 126
Pulkkinen, M., Pikkarainen, J. T., Wirth, T., TARVAINEN, T., Haapa‐aho, V., KORHONEN, H., Seppälä, J. V., & Järvinen, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.04.018 · Cited by 124
Destounis, S. V., DiNitto, P. A., Logan-Young, W. W., Bonaccio, E., Zuley, M. L., & Willison, K. M. (2004) · Radiology · doi:10.1148/radiol.2322030034 · Cited by 124
Mechanisms of iron uptake by mammalian cells
Qian, Z., & Tang, P. L. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(95)00098-x · Cited by 120
Gabizón, A., Tzemach, D., Gorin, J., Mak, L., Amitay, Y., Shmeeda, H., & Zalipsky, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1132-4 · Cited by 116
Cirstoiu-Hapca, A., Bossy-Nobs, L., Buchegger, F., Gurny, R., & Delié, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.002 · Cited by 116
Targeting of nanoparticles in cancer
Talekar, M., Kendall, J. D., Denny, W. A., & Garg, S. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834a4554 · Cited by 115
Chattopadhyay, N., Fonge, H., Cai, Z., Scollard, D. A., Lechtman, E., Done, S. J., Pignol, J., & Reilly, R. M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300016p · Cited by 115
Shah, N., Chaudhari, K., Dantuluri, P., Murthy, R. S. R., & Das, S. (2009) · Journal of drug targeting · doi:10.1080/10611860903046628 · Cited by 114
Sapra, P., Moase, E. H., Ma, J., & Allen, T. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0041 · Cited by 114
Targetable Gold Nanorods for Epithelial Cancer Therapy Guided by Near‐IR Absorption Imaging
Choi, J., Yang, J., Bang, D., Park, J., Suh, J., Huh, Y., & Haam, S. (2012) · Small · doi:10.1002/smll.201101789 · Cited by 111
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles
Hong, M., Zhu, S., Jiang, Y., Tang, G., Sun, C. Z., Fang, C., Shi, B., & Pei, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.024 · Cited by 106
Cho, Y., Yoon, T., Jang, E., Hong, K. S., Lee, S. Y., Kim, O. R., Park, C.-S., Kim, Y.-J., Yi, G., & Chang, K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.004 · Cited by 105
Adolphi, N. L., Butler, K. S., Lovato, D. M., Tessier, T. E., Trujillo, J. E., Hathaway, H. J., Fegan, D. L., Monson, T., Stevens, T., Huber, D. L., et al. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.499 · Cited by 101
Issues related to targeted delivery of proteins and peptides
Lu, Y. J., Yang, J. J. J., & Sega, E. I. (2006) · The AAPS Journal · doi:10.1208/aapsj080355 · Cited by 99
Chen, H., Gao, J., Lu, Y., Kou, G., Zhang, H., Fan, L., Sun, Z., Guo, Y., & Zhong, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.010 · Cited by 97
Zhao, N., Bagaria, H. G., Wong, M. S., & Zu, Y. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-2 · Cited by 97
Yang, H., Park, C. W., Woo, M., Kim, M. I., Jo, Y. M., Park, H. G., & Kim, J.-D. (2010) · Biomacromolecules · doi:10.1021/bm100560m · Cited by 97
Liao, C., Sun, Q., Liang, B., Shen, J., & Shuai, X. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.08.005 · Cited by 96
Patra, C. R., Bhattacharya, R., & Mukherjee, P. (2009) · Journal of Materials Chemistry · doi:10.1039/b913224d · Cited by 94
Sugano, M., Egilmez, N. K., Yokota, S. J., Chen, F.-A., Harding, J., Huang, S. K., & Bankert, R. B. (2000) · PubMed · Cited by 93
Ruan, J., Song, H., Qian, Q., Li, C., Wang, K., Bao, C., & Cui, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.053 · Cited by 89
Bouras, A., Kaluzová, M., & Hadjipanayis, C. G. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1807-0 · Cited by 86
Jiang, W., Xie, H., Ghoorah, D., Shang, Y., Shi, H., Liu, F., Yang, X., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037376 · Cited by 86
Shi, X., Wang, S. H., Antwerp, M. E. V., Chen, X., & Baker, J. R. (2009) · The Analyst · doi:10.1039/b902199j · Cited by 86
Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes
Derycke, A., & de Witte, P. A. M. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.1.181 · Cited by 83
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Ni, S., Stephenson, S. M., & Lee, R. J. (2002) · PubMed · Cited by 83
Song, E., Zhang, Z., Luo, Q., Lu, W. J., Shi, Y., & Pang, D. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113423 · Cited by 82
p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome
Nakase, M., Inui, M., Okumura, K., Kamei, T., Nakamura, S., & Tagawa, T. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0196 · Cited by 81
Li, G., Li, D., Zhang, L., Zhai, J., & Wang, E. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200900914 · Cited by 80
Marty, C., Odermatt, B., Schott, H. N., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600423 · Cited by 79
Targeting and Cellular Trafficking of Magnetic Nanoparticles for Prostate Cancer Imaging
Serda, R. E., Adolphi, N. L., Bisoffi, M., & Sillerud, L. O. (2007) · Molecular Imaging · doi:10.2310/7290.2007.00025 · Cited by 76
Rudolph, C., Schillinger, U., Plank, C., Gessner, A., Nicklaus, P., Müller, R., & Rosenecker, J. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00334-3 · Cited by 75
Targeted folic acid‐PEG nanoparticles for noninvasive imaging of folate receptor by MRI
Chen, T., Cheng, T., Hung, Y., Lin, K., Liu, G., & Wang, Y. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31752 · Cited by 74
Riviere, K., Huang, Z. R., Jerger, K., Macaraeg, N., & Szoka, F. C. (2010) · Journal of drug targeting · doi:10.3109/10611861003733953 · Cited by 68
Corsi, F., Fiandra, L., Palma, C. D., Colombo, M., Mazzucchelli, S., Verderio, P., Allevi, R., Tosoni, A., Nebuloni, M., Clementi, E., et al. (2011) · ACS Nano · doi:10.1021/nn201570n · Cited by 67
Controlled release of Rituximab from gold nanoparticles for phototherapy of malignant cells
Bisker, G., Yeheskely‐Hayon, D., Minai, L., & Yelin, D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.030 · Cited by 65
Taylor, R. M., Huber, D. L., Monson, T., Ali, A.-M. S., Bisoffi, M., & Sillerud, L. O. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0439-3 · Cited by 62
Cancer Detection and Treatment: The Role of Nanomedicines
LaRocque, J., Bharali, D. J., & Mousa, S. A. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9161-0 · Cited by 58
Deepagan, V. G., Sarmento, B. F. C. C., Menon, D., Nascimento, A. V., Jayasree, A., Sreeranganathan, M., Koyakutty, M., Nair, S. V., & Jayakumar, R. (2012) · Nanomedicine · doi:10.2217/nnm.11.139 · Cited by 56
Folate-targeting magnetic core–shell nanocarriers for selective drug release and imaging
Wang, H., Wang, S., Liao, Z., Zhao, P., Su, W., Niu, R., & Chang, J. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.009 · Cited by 55
Gao, X., Luo, & Wang (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32804 · Cited by 55
Asadishad, B., Vossoughi, M., & Alamzadeh, I. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0208-x · Cited by 54
Taylor, R. M., & Sillerud, L. O. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34381 · Cited by 52
Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells
FONSECA, C., Moreira, J. N., Ciudad, C. J., PEDROSODELIMA, M., & Simões, S. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.08.012 · Cited by 48
Corbin, I. R., Ng, K. K., Ding, L., Jurisicova, A., & Zheng, G. (2012) · Nanomedicine · doi:10.2217/nnm.12.137 · Cited by 45
In Situ Detection of Live Cancer Cells by Using Bioprobes Based on Au Nanoparticles
Yang, J., Eom, K., Lim, E., Park, J., Kang, Y., Yoon, D. S., Na, S., Koh, E. K., Suh, J., Huh, Y., et al. (2008) · Langmuir · doi:10.1021/la802184m · Cited by 39
Parab, H. J., Huang, J., Lai, T., Jan, Y., Liu, R., Wang, J.-L., Hsiao, M., Chen, C., Hwu, Y., Tsai, D. P., et al. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/39/395706 · Cited by 32
Liu, D., Chen, C., Hu, G., Mei, Q., Qiu, H., Long, G., & Hu, G. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr010 · Cited by 17
In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-4636(200007)51:1 · Cited by 4
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Metadata
- Authors
- Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T.
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 2014-07-09
- Volume
- 141
- Issue
- 5
- Pages
- 769-784
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- OpenAlex
- W2072210671
- Cited by
- 756
- References
- 143
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.